MARKET

BMEA

BMEA

Biomea Fusion, Inc.
NASDAQ
2.000
+0.070
+3.63%
After Hours: 2.000 0 -0.01% 19:28 07/11 EDT
OPEN
1.910
PREV CLOSE
1.930
HIGH
2.010
LOW
1.870
VOLUME
729.70K
TURNOVER
--
52 WEEK HIGH
13.07
52 WEEK LOW
1.291
MARKET CAP
114.04M
P/E (TTM)
-0.5640
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BMEA last week (0630-0704)?
Weekly Report · 5d ago
Biomea Fusion’s Phase 2 Trial: A New Hope for Type 1 Diabetes Treatment
TipRanks · 07/03 16:27
Biomea Fusion’s BMF-219 Study: A Potential Game-Changer for Type 2 Diabetes
TipRanks · 07/03 16:13
Biomea Fusion’s BMF-219 Study Update: Implications for Investors
TipRanks · 07/03 16:01
Weekly Report: what happened at BMEA last week (0623-0627)?
Weekly Report · 06/30 09:21
Largest borrow rate increases among liquid names
TipRanks · 06/25 12:45
Largest borrow rate increases among liquid names
TipRanks · 06/24 12:45
Biomea Fusion Is Maintained at Buy by D. Boral Capital
Dow Jones · 06/24 12:26
More
About BMEA
Biomea Fusion, Inc. is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small molecules to improve the lives of patients with diabetes, obesity, and metabolic diseases. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company has built its proprietary FUSION System discovery platform to advance a pipeline of small molecule product candidates. Its lead clinical program’s drug candidate, icovamenib, is being developed as an orally bioavailable, and selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib’s potential in type 1 and type 2 diabetes, as well as its impact in obesity. Its second product candidate BMF-650, is an investigational, oral small-molecule glucagon-like peptide-1 receptor agonists (GLP-1 RA), for the treatment of diabetes and obesity.

Webull offers Biomea Fusion Inc stock information, including NASDAQ: BMEA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMEA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMEA stock methods without spending real money on the virtual paper trading platform.